BBBàrbara Baro

Bàrbara Baro

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bàrbara Baro has a total of 223 co-authors. Here are the top co-authors by number of shared publications:

  • Quique Bassat

    Affiliations Centro de Investigação em Saúde de Manhiça [CISM], Maputo, Mozambique, ISGlobal - Hospital Clínic, Universitat de Barcelona, Barcelona, Spain, Institutó Catalana de Recerca i Estudis Avançats [ICREA], Barcelona, Spain, Pediatrics Department, Hospital Sant Joan de Déu, Universitat de Barcelona, Esplugues, Barcelona, Spain, CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain

    9 shared publications
  • Oriol Mitjà

    Fight Infectious Diseases Foundation, Badalona, Spain

    7 shared publications
  • Andrea Alemany

    ISGlobal, Barcelona, Spain

    6 shared publications
  • Quique Bassat

    ISGlobal

    6 shared publications
  • Dan Ouchi

    ISGlobal

    5 shared publications
  • Jordi Ara

    Hospital Universitari Germans Trias I Pujol, Badalona, Spain

    5 shared publications

Latest Publications

  • Open Access

    Serum and cerebrospinal fluid biomarkers for risk stratification of hospitalized neonates and young infants with suspected serious bacterial infections: a secondary analysis of a prospective cohort study

    by Chaymae El Abbass, Luis Alberto Benegas, Andrea Alemany, Cristina Garcia-Mauriño, Ilham Elouardighi, Imane Zizi, Najat Amalik, Lamya El Laziji, Sobha El Ftouh, Rachid Babi, et al.

    Background: Improved risk stratification strategies for neonates and young infants are urgently needed to reduce the substantial mortality burden associated with infectious diseases, particularly in low- and middle-income settings. Evidence supporting the use of host-response biomarkers to predict disease severity in this population remains limited. Methods: We conducted a secondary analysis of a prospective cohort study at a National Reference Neonatology Centre in Morocco and evaluated the prognostic performance of host-response biomarkers measured in serum and cerebrospinal fluid (CSF) to predict in-hospital mortality among hospitalized sick neonates and young infants (<2 months). Twenty-one biomarkers of immune activation, endothelial dysfunction, and neuronal injury were measured using Luminex and compared head-to-head. Results: Among 179 participants with available serum and/or CSF samples included in this analysis, 9% died during hospitalization (11/136 in the serum sample set, and 12/148 in the CSF sample set). In serum, lower concentrations of TRAIL and higher concentrations of Angpt-2, IL-8, and uPAR, were associated with in-hospital death, with TRAIL showing the strongest prognostic performance (AUROC 0.86; 95% CI 0.78-0.93). In CSF, PCT was the strongest predictor of severe progression for in-hospital death (AUROC 0.87; 95% CI 0.80-0.95), whereas higher levels of IL-6, IL-12p70, TNFR1, TREM-1, Angpt-1, NGAL, and NSE were associated with higher odds of probable or laboratory-confirmed meningitis. Discussion: Serum levels of TRAIL showed an exploratory association with disease severity in hospitalized neonates and young infants with suspected serious bacterial infections. Larger multicenter studies are needed to validate these findings using multiple biological matrices, characterize kinetics, and determine whether these markers may have clinical utility for risk stratification in this vulnerable population.

  • Open Access

    Biotin-specific molecularly imprinted polymers as a biomimetic test line in lateral flow assays

    by Jennifer Marfà, Anaixis del Valle, Rafael Rovatti Pupin, Bàrbara Baro, Quique Bassat, Maria Del Pilar Taboada Sotomayor, María Isabel Pividori


  • Open Access

    Epidemiology and Outcomes of Pediatric Fever in a Rural District of Southern Mozambique: 17 Years of Morbidity Surveillance

    by David Torres-Fernandez, Jessica Dalsuco, Cristina Garcia-Mauriño, Núria Balanza, Marta Valente, Sara Ajanovic, Rosauro Varo, Jaime Fanjul, Justina Bramugy, Antonio Sitoe, et al.

    Background: Pediatric febrile illnesses remain a leading cause of health care visits, morbidity, and mortality in low-resource settings. Their etiological diagnosis and outcome evaluation are challenging as available tools are limited. Herein, we describe the epidemiology, trends, and clinical outcomes of febrile pediatric outpatient clinic visits and inpatients during a 17-year-long period in Southern Mozambique. Methods: We retrospectively analyzed surveillance morbidity and demographic data from children <15 years old presenting with fever (≥37.5°C) at Manhiça District Hospital and 5 peripheral health posts from 2004 to 2020. We characterized diagnoses and clinical signs, stratified by outpatient clinic visits and hospitalizations, and calculated 7-day mortality odds, case fatality ratios (CFRs), and minimum community-based incidence rates. Results: A total of 664 223 outpatient visits and 23 166 hospitalizations were included. The median age (interquartile range) was 47.1 (20.0–92.3) months for outpatients and 21.2 (10.1–41.5) months for inpatients. The most frequent first encounter diagnoses included malaria (33.5%), upper (27.8%) and lower (10.1%) respiratory tract infections, and acute gastrointestinal infection (6.0%), whose frequencies showed a marked annual decline from 2004 to 2020, particularly among inpatients. All-cause 7-day mortality was 0.1% and 2.2% among outpatients and inpatients, respectively. Sepsis and meningitis were less common but presented the highest CFRs (9%–16%). Malnutrition and HIV infection were major contributors to inpatient mortality. Seizures, edema, dehydration, and reduced consciousness were strong predictors of death. Conclusions: Malaria, respiratory tract, and acute gastrointestinal infections represented the predominant causes of fever and mortality, with decreasing trends over time. This analysis underscores the value of epidemiological surveillance and the need for improved early diagnosis and clinical management tools for febrile children.


  • Open Access

    Plasmodium falciparum exploits NUAK1 to establish infection in human erythrocytes

    by Daniel J. Navarrete, Chi Yong Kim, Kyle McLelland, Mario Gonzalez Ramirez, Barbara Baro, Nichole D. Salinas, Niraj H. Tolia, Christian Doerig, Shao-En Ong, Martin G. Golkowski, et al.

    The malaria parasite Plasmodium falciparum continues to demonstrate growing drug resistance, raising the need for innovative treatments. Host-directed therapeutics are emerging as a promising approach for many infectious diseases, but knowledge of critical host factors for malaria is limited. P. falciparum is an obligate intracellular parasite of human erythrocytes, suggesting it has evolved to exploit specific host pathways to establish infection. Here, we report that the AMPK-related kinase NUAK1 is a critical host factor for P. falciparum in erythrocytes and has potential as a therapeutic target. We show that NUAK1 is present in human erythrocytes and undergoes increased phosphorylation in P. falciparum -infected cells. Two highly selective NUAK1 inhibitors, HTH-01-015 and WZ4003, inhibited P. falciparum growth throughout its asexual life cycle, including during erythrocyte invasion. Chemoproteomic profiling confirmed the inhibitors’ selectivity for human NUAK1. We further show that treatment with the inhibitors reduces phosphorylation of the well-characterized NUAK1 substrate MYPT1 in erythroid cells. Moreover, we find that genetic overexpression of NUAK1 in erythroid cells partially rescues both the signaling and invasion phenotypes elicited by the small molecule inhibitors. These results establish a critical role for the NUAK1 signaling pathway in P. falciparum -infected erythrocytes and highlight its potential as a vulnerable target for host-directed malaria control.

  • Open Access

    Soluble triggering receptor expressed on myeloid cells 1 (sTREM-1) predicts mortality in patients with febrile illness in southern Mozambique

    by Núria Balanza, Bàrbara Baro, Sara Ajanovic, Zumilda Boca, Justina Bramugy, Anelsio Cossa, Elizabeth Ja. Fitchett, Heidi Hopkins, Suzanne H. Keddie, Sham Lal, et al.

    Background: Fever is a leading reason for seeking healthcare globally. Early in the course of febrile illness, it is challenging to identify patients at risk of severe and fatal infections. Quantifying biomarkers of immune and endothelial activation may facilitate patient triage. Methods: We prospectively enrolled children ≥2 months and adults with fever visiting two Mozambican hospitals from December 2018 to February 2021. Standard clinical and laboratory parameters, including lactate levels, were assessed at presentation. Plasma levels of Angpt-2, CHI3L1, CRP, IL-6, IL-8, PCT, sFlt-1, sTNFR1, sTREM-1, and suPAR at presentation were retrospectively quantified. Clinical outcomes were evaluated up to 28 days. We assessed the prognostic performance of biomarkers for 28-day mortality and explored their association with other adverse outcomes. Results: This study includes 1955 participants, with 93 deaths occurring within 28 days. We show that all biomarker levels are elevated in inpatients compared to outpatients and are associated with 28-day mortality (all p < 0.001). sTREM-1 is the best biomarker predicting 28-day mortality with an AUROC of 0.82 (95% CI: 0.78-0.86), superior to that of PCT (p < 0.001), CRP (p < 0.001), and lactate (p = 0.0033). Its prognostic performance is consistent across age and sex, but is reduced in HIV-positive individuals (AUROC = 0.73, 95% CI: 0.66-0.80). Adding sTREM-1 improves the discrimination of clinical severity scores for 28-day mortality. Among discharged inpatients, sTREM-1 is positively correlated with duration of hospitalisation (p < 0.001). Among outpatients, sTREM-1 levels are higher in those seeking further care (p = 0.0022) or subsequently hospitalised (p = 0.012). Conclusions: sTREM-1 is a promising biomarker for risk stratification of all-age, all-cause febrile illnesses in resource-limited settings.


  • Open Access

    Prognostic performance of early immune and endothelial activation markers in mild-to-moderate COVID-19 outpatients: a nested case-control study

    by Andrea Alemany, Núria Balanza, Pere Millat-Martinez, Dan Ouchi, Marc Corbacho-Monné, Cristian Morales-Indiano, Gema Fernández Rivas, Ignacio Blanco, Oriol Mitjà, Ruth Aguilar, et al.

    Introduction: Evidence on the association of biomarkers of host response to infection with COVID-19 clinical outcomes has focused mainly on hospitalized patients. We investigated the prognostic performance of 39 immune and endothelial activation markers measured early in the course of disease to predict the development of severe COVID-19 and hospitalization.Methods: We conducted a nested case-control study from a randomized clinical trial evaluating the efficacy of COVID-19 convalescent plasma in outpatients aged 50 years or older presenting with mild-to-moderate COVID-19. We selected participants who were hospitalized within 28 days (cases) and who were not (controls) to compare their biomarker levels in plasma samples collected at enrolment.Results: A total of 42 cases and 42 controls were included in this study. The levels of CRP, IL6, IP10, ferritin, IFNα, IL8, IL1RA, MCP1, and RANTES, determined within 7 days of symptoms onset, showed good individual prognostic performance for COVID-19 associated hospitalization by day 28. The biomarkers CRP, IL6, IP10, IL8, IL1RA, and suPAR showed good individual prognostic performance for severe COVID-19. CRP, IL6 and IP10 had the most robust association with both hospitalization and severe COVID-19, with CRP having the highest discriminatory capacity with hospitalization, and IL6 for severe COVID-19.Discussion: Our study shows good prognostic performance of CRP and IL6 for 28-day hospitalization in patients with mild-to-moderate COVID-19, in the absence of clinical criteria for admission upon enrolment. These findings confirm the value of these biomarkers at early stages of COVID-19 disease in the outpatient setting to support management decisions.


  • Open Access

    Author Correction: Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients

    by Pere Millat-Martinez, Arvind Gharbharan, Andrea Alemany, Casper Rokx, Corine Geurtsvankessel, Grigorios Papageorgiou, Nan van Geloven, Carlijn Jordans, Geert Groeneveld, Francis Swaneveld, et al.

  • Open Access

    Plasmodium falciparum exploits CD44 as a coreceptor for erythrocyte invasion

    by Barbara Baro, Chi Yong Kim, Carrie Lin, Angel K. Kongsomboonvech, Marilou Tetard, Nana Ansuah Peterson, Nichole D. Salinas, Niraj H. Tolia, Elizabeth S. Egan

    The malaria parasite Plasmodium falciparum invades and replicates asexually within human erythrocytes. CD44 expressed on erythrocytes was previously identified as an important host factor for P falciparum infection through a forward genetic screen, but little is known about its regulation or function in these cells, nor how it may be used by the parasite. We found that CD44 can be efficiently deleted from primary human hematopoietic stem cells using CRISPR/Cas9 genome editing, and that the efficiency of ex vivo erythropoiesis to enucleated cultured red blood cells (cRBCs) is not affected by lack of CD44. However, the rate of P falciparum invasion was reduced in CD44-null cRBCs relative to isogenic wild-type control cells, validating CD44 as an important host factor for this parasite. We identified 2 P falciparum invasion ligands as binding partners for CD44, erythrocyte binding antigen 175 (EBA-175) and EBA-140 and demonstrated that their ability to bind to human erythrocytes relies primarily on their canonical receptors, glycophorin A and glycophorin C, respectively. We further show that EBA-175 induces phosphorylation of erythrocyte cytoskeletal proteins in a CD44-dependent manner. Our findings support a model in which P falciparum exploits CD44 as a coreceptor during invasion of human erythrocytes, stimulating CD44-dependent phosphorylation of host cytoskeletal proteins that alter host cell deformability and facilitate parasite entry.


  • Open Access

    A cross-sectional study to ascertain malaria prevalence among asymptomatic travellers arriving on the Lihir Group of Islands, Papua New Guinea: implications for elimination efforts

    by Pere Millat-Martínez, Bàrbara Baro, Bernadine Kasian, Lina Lorry, Sergi Sanz, Chilaka Wali, Sylvia Raulo, Arthur Elizah, Tamarah Koleala, Maria Kaius-Ome, et al.

    Background: The Lihir Islands of Papua New Guinea host a mining operation that has resulted in a mine-impacted zone (MIZ) with reduced malaria transmission and a substantial influx of mine employees, informal cross-country traders, returning locals, and visitors. Prevalence of malaria parasites was assessed in travellers arriving on the Lihir Group of Islands to evaluate the risk of parasite importation. Methods: In 2018, a cross-sectional study at the airport and main wharf was conducted, targeting asymptomatic travellers who had been away from Lihir for at least 12 days. Microscopy, rapid diagnostic tests (RDTs), and quantitative PCR (qPCR) were used to determine Plasmodium parasite prevalence, employing logistic regression models to identify factors associated with qPCR positivity. Results: 398 travellers arriving by plane and 402 arriving by boat were included. Both cohorts were significantly different. Mean age among travellers arriving by plane was 40.1 years (SD ± 10.1), 93% were male and 96% were employed at the mine. In contrast, among travellers arriving by boat, the mean age was 31.7 years (SD ± 14.0), 68% were male and 36% were employed at the mine. The prevalence of malaria infection among travellers arriving by plane was 1% by RDT and microscopy, and increased to 5% by qPCR. In contrast, those arriving by boat showed a prevalence of 8% by RDT and microscopy, and 17% by qPCR. Risk factors for infection were arriving by boat (OR 4.2; 95%CI 2.45,7.21), arriving from nearby provinces with high malaria incidence (OR 5.02; 95%CI 1.80, 14.01), and having been away from Lihir for 91 days or more (OR 4.15; 95%CI 2.58, 6.66). Being mine worker staying at the mine accommodation was related with less infection risk (OR 0.24; 95% CI 0.14, 0.43); while Lihirian residents returning from a trip, VFRs, or people with trading unrelated to mining had higher risks (p = 0.0066). Conclusions: Travellers arriving by boat faced increased risk of malaria infection than those arriving by plane. This subpopulation poses an import risk to the MIZ and the rest of Lihir Islands. Screening of high-risk groups at wharfs, and collaboration with nearby Islands, could sustain reduced transmission and facilitate malaria elimination strategies.


  • Open Access

    Reply to Zayet et al

    by Núria Balanza, Caroline K Francis, Valerie M Crowley, Andrea M Weckman, Kathleen Zhong, Bàrbara Baro, Rosauro Varo, Quique Bassat, Kevin C Kain

    Núria Balanza, Caroline K Francis, Valerie M Crowley, Andrea M Weckman, Kathleen Zhong, Bàrbara Baro, Rosauro Varo, Quique Bassat, Kevin C Kain; Reply to Zayet